undamentalytics Newsletter
Sign in

Community Health Systems Inc (CYH) stock

Add to watchlist

Add holding +

NYSE: CYH NYSE Hospitals Next results ~February 17, 2027

E Fundamentals grade

Community Health Systems Inc is a US-listed company in the hospitals industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$9.9

Growth cash-flow model

Base case. Range ~$9.9–$20. Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability.

Price vs value

No Buy/Hold/Sell rating is issued: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Community Health Systems Inc valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders0 buying, 1 selling0 purchases and 1 sale by directors and officers, last 12 monthsInsider trades
  • Funds95 adding, 76 cuttingOf 36 active managers that changed their stake, 22 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Community Health Systems files

10-Q filed October 29: Community Health Systems

Model value −1.3%

Community Health Systems reported revenue of $11.7bn for the twelve months to September 2026, a 7.8% fall on the prior year. This marks a steeper decline than the 5.3% drop seen a quarter earlier, suggesting the slowdown is gathering pace. Profitability has also weakened: free-cash-flow margin turned negative, slipping to -1.0% from 1.1% a year before. Reflecting this, our model value has been revised down, moving from $10.40 to $10.26 a share. Against that backdrop, the stock trades at just $2.40, a wide gap to either estimate.

Source: 10-Q filed October 29, 2026 on SEC EDGAR · Financials · Valuation

Earlier notes (2)

10-Q filed July 23: Community Health Systems

Community Health Systems posted revenue of $11.7bn for the twelve months to June 2026, a 7.8% drop on the prior year. That decline has steepened markedly, having stood at just 5.3% a quarter earlier. Profitability also weakened: free-cash-flow margin slipped to -1.0%, down from 1.1% twelve months before. These shifts have prompted a cut to our model value, which now stands at $10.40 a share, down from $11.54 previously. Against this, the shares trade at $2.27, leaving a wide gap between our estimate and the market price. The pace of the revenue slide, in particular, marks a notable deterioration from the trend seen in the prior quarter.

10-Q on SEC EDGAR

Where Community Health Systems stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $12.0bn, down 5.3% on a year earlier, a steeper fall than the 2.9% decline a quarter earlier. Free-cash-flow margin fell to -1.5% from 1.1% a year earlier. Operating margin widened to 11.4% from 6.9%. The diluted share count is up 2.0% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades E. It passes 1 of our 4 financial-health checks. Our valuation models combined value is $11.54 a share, against a share price of $2.94.

10-Q on SEC EDGAR

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~February 17, 2027 (estimated)

Community Health Systems Inc's trailing-twelve-month revenue fell 7.8% year on year, with a free-cash-flow margin of -1.0%. Where it lags: revenue growth of -7.8% ranks 5 of 5 hospitals companies we cover.

Current signal Revenue growth decelerating: TTM revenue growth slowed to -7.8% (-2.6pp vs the prior quarter), the 7th consecutive quarterly slowdown.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

Nothing in Community Health Systems Inc's latest figures clears our strength thresholds.

Things to watch

  • Revenue shrinking. Revenue fell 7.8% over the last 12 months.
  • Burning cash. Free cash flow was -1.0% of revenue over the last 12 months.
  • Volatile shares. Over the past year the shares showed annualised volatility of 52% and a beta of 1.0 against the S&P 500.
  • Growth easing. The growth rate is 2.6 points lower than a quarter earlier.
  • Weak cash conversion. Free cash flow was -339% of net income over the last 12 months.
  • Below peers: net margin. Net margin of 0.3% ranks 5 of 5 hospitals companies we cover (median 7.7%).

Latest results: FY2026 Q3

Filed October 29, 2026
Earnings per share
-$0.48 against an average estimate of -$0.32: missed by 48.0%
Revenue
$2.76bn, down 10.7% on a year earlier
Share reaction
-15.1% in the first session after the results on October 28, 2026, against 0.0% for the S&P 500
Guidance given
net operating revenues $11,300m to $11,500m (year ending December 31, 2026); adjusted EBITDA $1,225m to $1,275m (year ending December 31, 2026)
Next report
October 28, 2026; average EPS estimate -$0.14

Community Health Systems' figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-12.5%
  • 1 week-28.6%
  • 1 month-22.8%
  • This year-32.7%
  • 1 year-45.9%
  • 5 years-84.5%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$11.7B
Operating margin
10.9%
Net margin
0.3%
EPS (TTM, diluted)
$0.26

Growth

Revenue growth
−7.8%
Change in growth rate
−2.6 pts
Share count change
+1.5%

Cash

Free cash flow (TTM)
-$122M
FCF margin
-1.0%
Stock pay % of revenue
0.1%

Earnings

Last results
October 28, 2026
Next results (est.)
February 17, 2027

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Guidance
  3. Our research
  4. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Community Health Systems Inc valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Valuation models

We value Community Health Systems Inc as an operating company, with every model that fits that kind of business. Cost of equity 10.5%: the 10-year Treasury yield (4.9%) plus a beta of 1.23 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$9.9 Primary model, counts double
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: fewer than 5 peers with a usable multiple
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: book value or earnings not available
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: return on equity is not positive
Forward price-to-sales vs peers Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative. Uses analysts' consensus estimates (third-party data), not our forecasts. — Does not apply: earnings are positive: price-to-earnings is the better measure
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. ~$15 ~$15–$37 Left out: out of range vs price (7.00x)
Combined value Weighted average of the models that apply: the primary model (growth cash-flow model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$9.9 ~$9.9–$20 1 model

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Community Health Systems Inc with Health Care sector in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 2016201720182019202020212022202320242025Now
Share price$5.59$4.26$2.82$2.90$7.43$13.31$4.32$3.13$2.99$3.12$2.10
Market value$619m$476m$318m$330m$866m$1.7bn$562m$408m$395m$421m$285m
+ Net debt (− = net cash)$15.2bn$13.5bn$13.6bn$13.3bn$10.8bn$12.1bn$11.9bn$11.8bn$11.7bn$10.4bn$9.4bn
Enterprise value$15.8bn$14.0bn$13.9bn$13.7bn$11.7bn$13.8bn$12.5bn$12.2bn$12.1bn$10.8bn$9.7bn
Multiples
Price / sales 0.0x0.0x0.0x0.0x0.1x0.1x0.0x0.0x0.0x0.0x0.0x
Price / earnings ————1.7x7.6x12.2x——0.8x7.9x
Price / free cash flow 1.6x2.3x——0.5x———3.3x2.0x—
EV / EBITDA 65.9x—15.3x10.9x6.9x7.1x9.2x8.3x11.8x5.6x5.7x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

40 /100

Weak moat

How hard Community Health Systems's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median -0.5% of total assets over 10 years.

  • Pricing power 20 / 20

    Gross margin has been a median 83.8%, moving by 0.8 percentage points (standard deviation) across 9 years.

  • Durability 1 / 20

    Operating margin has been a median 7.2%; its worst year was -13.3%.

  • Cash conversion 4 / 20

    Free cash flow was positive in 4 of 9 years, at a median -0.1% of revenue.

  • Discipline 14 / 20

    The diluted share count rose 6.9% over five years; stock-based pay has been a median 0.1% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current −$1.24 −204% $11.4bn −9%
Next −$0.59 +52% $11.5bn +1%

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +6.0% on 90 days ago. In the last 30 days, 0 analysts raised Community Health Systems Inc's forecast and 4 cut it.

Consensus EPS forecast Community Health Systems Inc, last 90 days
−$1.50 −$1.00 −$0.50 $0.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: −$1.17 Current fiscal year, 60 days ago: −$1.17 Current fiscal year, 30 days ago: −$1.17 Current fiscal year, 7 days ago: −$1.17 Current fiscal year, Now: −$1.24 −$1.24 Next fiscal year, 90 days ago: −$0.53 Next fiscal year, 60 days ago: −$0.52 Next fiscal year, 30 days ago: −$0.52 Next fiscal year, 7 days ago: −$0.52 Next fiscal year, Now: −$0.59 −$0.59

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago −$1.17−$0.53
60 days ago −$1.17−$0.52
30 days ago −$1.17−$0.52
7 days ago −$1.17−$0.52
Now −$1.24−$0.59

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 −$0.32 −$0.48 −48.0%
Jun 2026 −$0.10 −$0.19 −83.4%
Mar 2026 −$0.09 −$0.48 −461.4%
Dec 2025 −$0.20 $0.00 +100.0%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, October 28, 2026
  • Net operating revenues year ending December 31, 2026 $11,300m to $11,500m Lowered vs 11,400m to 11,600m
    “Net operating revenues (in millions) $ 11,300 to $ 11,500” source
  • Net loss per share - diluted year ending December 31, 2026 $-1.70 to $-1.60 GAAP Lowered vs -1.25 to -1.1
    “Net loss per share - diluted $ (1.70 ) to $ (1.60 )” source
  • Adjusted EBITDA year ending December 31, 2026 $1,225m to $1,275m Non-GAAP Lowered vs 1,300m to 1,375m
    “Adjusted EBITDA (in millions) $ 1,225 to $ 1,275” source
  • Weighted-average diluted shares 2026 136m to 136m Maintained vs about 136m
    “Weighted-average diluted shares (in millions) 136 to 136” source
  • Depreciation and amortization as a % of net operating revenues 2026 3.8% to 3.9% Raised vs 1.2 to 1.3
    “Expressed as a percentage of net operating revenues, depreciation and amortization of approximately 3.8% to 3.9% for 2026.” source
  • Interest expense 2026 $820m to $830m Raised vs 30m to 50m
    “Interest expense is estimated to be between $820 million and $830 million while cash paid for interest, which excludes the amortization of deferred financing costs, is expected to be between $800 million and $810 million.” source
Show 6 more items
  • Cash paid for interest 2026 $800m to $810m Raised vs 30m to 50m
    “Interest expense is estimated to be between $820 million and $830 million while cash paid for interest, which excludes the amortization of deferred financing costs, is expected to be between $800 million and $810 million.” source
  • Fixed rate debt as % of total debt 2026 about 98% Raised vs 1.2 to 1.3
    “Total fixed rate debt is expected to average approximately 98% of total debt during 2026.” source
  • Net income attributable to noncontrolling interests as % of net operating revenues 2026 1.2% to 1.3% Maintained vs 1.2 to 1.3
    “Expressed as a percentage of net operating revenues, net income attributable to noncontrolling interests of approximately 1.2% to 1.3% for 2026.” source
  • Provision for income taxes as % of net operating revenues 2026 0.8% to 0.9% Maintained vs 0.8 to 0.9
    “Expressed as a percentage of net operating revenues, provision for income taxes of approximately 0.8% to 0.9% for 2026.” source
  • Capital expenditures 2026 $350m to $400m Maintained vs 350m to 400m
    “Total $ 350 to $ 400” source
  • Diluted weighted-average shares outstanding 2026 about 136m Maintained vs about 136m
    “Diluted weighted-average shares outstanding are projected to be approximately 136 million for 2026.” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

Analyst recommendations

10 analysts, Oct 2026
Buy220%
Hold550%
Sell330%

Monthly trend

  1. Oct 20261151210
  2. Sep 20261151210
  3. Aug 2026114129
  4. Jul 2026114129

Counts of recommendations published by analysts covering Community Health Systems Inc, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
9.4%
of tradable shares
Days to cover
10.51
at average volume
Short interest, 1 month
−9%
to October 15, 2026
Held by institutions
84%
of shares
Held by insiders
15.2%
of shares
Employees
44,000
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −45.9%

$3.88 on October 31, 2025 to $2.10

ThenNowEffect
Revenue (last 12 months) $12.6bn $12.0bn −5.3%
P/S multiple 0.0x 0.0x −41.7%
Share count 133m 136m −2.0%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

Last 3 years −16.0%

$2.50 on November 3, 2023 to $2.10

ThenNowEffect
Revenue (last 12 months) $12.4bn $12.0bn −3.3%
Net margin 2.3% 2.1% −8.3%
P/E multiple 1.2x 1.1x −1.8%
Share count 131m 136m −3.6%

Biggest factor: net margin.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
CYH+79%−68%−28%−5%+4%−33%
Industry peers (median)+11%−40%+13%+41%+37%+34%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
CYH50%33%50%50%50%36%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
CYH−41%−86%−74%−52%−44%−46%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 93% from November 6, 2015 to August 27, 2019. Getting back needed a 1345% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$2.10 – $3.90
From 52-week high
−46.2%
vs 50-day average
−26.3%
vs 200-day average
−30.6%
Volatility (1 year)
52%
Beta vs S&P 500
0.97

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
6 up, 6 down
typical move ±16.7%
After a week
6 up, 5 down
typical move ±20.1%
After a month
3 up, 8 down
typical move ±20.6%
Results releasedNext dayS&P 500 next day5 days21 days
October 28, 2026 −15.1% 0.0% — —
July 22, 2026 −13.4% −1.3% −15.6% −7.2%
April 21, 2026 −14.0% +0.4% −8.6% −10.8%
February 18, 2026 +2.3% +0.2% +5.8% −12.8%
October 23, 2025 +26.9% +1.4% +27.9% −3.4%
July 23, 2025 −24.5% +0.9% −34.4% −30.5%
April 23, 2025 +19.5% +3.7% +13.3% +54.4%
February 18, 2025 +6.8% +0.5% +16.0% −19.2%
October 23, 2024 −22.6% −0.7% −21.3% −31.7%
July 24, 2024 +17.5% −2.8% +29.9% +20.2%
April 24, 2024 +9.8% −0.4% +16.2% +19.9%
February 20, 2024 −28.4% −0.5% −31.9% −16.0%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Community Health Systems Inc in five measures

Fundamentals grade E
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Community Health Systems Inc
$11.5B $12B $12.5B $13B FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue (TTM), FY23 Q4: $12.5B Revenue (TTM), FY24 Q1: $12.5B Revenue (TTM), FY24 Q2: $12.5B Revenue (TTM), FY24 Q3: $12.6B Revenue (TTM), FY24 Q4: $12.6B Revenue (TTM), FY25 Q1: $12.7B Revenue (TTM), FY25 Q2: $12.6B Revenue (TTM), FY25 Q3: $12.6B Revenue (TTM), FY25 Q4: $12.5B Revenue (TTM), FY26 Q1: $12.3B Revenue (TTM), FY26 Q2: $12B Revenue (TTM), FY26 Q3: $11.7B $11.7B

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period Revenue (TTM)
FY23 Q4 $12.5B
FY24 Q1 $12.5B
FY24 Q2 $12.5B
FY24 Q3 $12.6B
FY24 Q4 $12.6B
FY25 Q1 $12.7B
FY25 Q2 $12.6B
FY25 Q3 $12.6B
FY25 Q4 $12.5B
FY26 Q1 $12.3B
FY26 Q2 $12B
FY26 Q3 $11.7B
Revenue growth, TTM YoY Community Health Systems Inc
-10% -5% 0% 5% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue growth, TTM YoY, FY23 Q4: 2.3% Revenue growth, TTM YoY, FY24 Q1: 2.6% Revenue growth, TTM YoY, FY24 Q2: 1.3% Revenue growth, TTM YoY, FY24 Q3: 0.8% Revenue growth, TTM YoY, FY24 Q4: 1.2% Revenue growth, TTM YoY, FY25 Q1: 1.0% Revenue growth, TTM YoY, FY25 Q2: 0.8% Revenue growth, TTM YoY, FY25 Q3: 0.7% Revenue growth, TTM YoY, FY25 Q4: -1.2% Revenue growth, TTM YoY, FY26 Q1: -2.9% Revenue growth, TTM YoY, FY26 Q2: -5.3% Revenue growth, TTM YoY, FY26 Q3: -7.8% -7.8%

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 2.3%
FY24 Q1 2.6%
FY24 Q2 1.3%
FY24 Q3 0.8%
FY24 Q4 1.2%
FY25 Q1 1.0%
FY25 Q2 0.8%
FY25 Q3 0.7%
FY25 Q4 -1.2%
FY26 Q1 -2.9%
FY26 Q2 -5.3%
FY26 Q3 -7.8%
Operating margin (TTM) Community Health Systems Inc
4% 6% 8% 10% 12% 14% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Operating margin (TTM), FY23 Q4: 7.7% Operating margin (TTM), FY24 Q1: 7.8% Operating margin (TTM), FY24 Q2: 7.7% Operating margin (TTM), FY24 Q3: 4.7% Operating margin (TTM), FY24 Q4: 4.3% Operating margin (TTM), FY25 Q1: 4.7% Operating margin (TTM), FY25 Q2: 6.9% Operating margin (TTM), FY25 Q3: 10.4% Operating margin (TTM), FY25 Q4: 11.9% Operating margin (TTM), FY26 Q1: 12.1% Operating margin (TTM), FY26 Q2: 11.4% Operating margin (TTM), FY26 Q3: 10.9% 10.9%

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q4 7.7%
FY24 Q1 7.8%
FY24 Q2 7.7%
FY24 Q3 4.7%
FY24 Q4 4.3%
FY25 Q1 4.7%
FY25 Q2 6.9%
FY25 Q3 10.4%
FY25 Q4 11.9%
FY26 Q1 12.1%
FY26 Q2 11.4%
FY26 Q3 10.9%
FCF margin (TTM) Community Health Systems Inc
-3% -2% -1% 0% 1% 2% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 FCF margin (TTM), FY23 Q4: -2.1% FCF margin (TTM), FY24 Q1: -1.1% FCF margin (TTM), FY24 Q2: -0.8% FCF margin (TTM), FY24 Q3: -0.1% FCF margin (TTM), FY24 Q4: 0.9% FCF margin (TTM), FY25 Q1: 1.2% FCF margin (TTM), FY25 Q2: 1.1% FCF margin (TTM), FY25 Q3: 1.1% FCF margin (TTM), FY25 Q4: 1.7% FCF margin (TTM), FY26 Q1: -1.6% FCF margin (TTM), FY26 Q2: -1.5% FCF margin (TTM), FY26 Q3: -1.0% -1.0%

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q4 -2.1%
FY24 Q1 -1.1%
FY24 Q2 -0.8%
FY24 Q3 -0.1%
FY24 Q4 0.9%
FY25 Q1 1.2%
FY25 Q2 1.1%
FY25 Q3 1.1%
FY25 Q4 1.7%
FY26 Q1 -1.6%
FY26 Q2 -1.5%
FY26 Q3 -1.0%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q, 10-Q/A. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2025, from the 10-K

Each dollar Community Health Systems took in during FY2025, followed through to profit: what it cost to make, what went on running the business, and what was left after tax.

  1. Revenue $12.5B
  2. Cost of revenue $1.9B · 14.9%
  3. Gross profit $10.6B · 85.1%
  4. Other operating costs $9.1B · 73.2%
  5. Operating income $1.5B · 11.9%
  6. Interest and other $931M · 7.5%
  7. Net income $509M · 4.1%

Shares of revenue. Source: Community Health Systems's 10-K for FY2025, as filed with the SEC. "Other" lines are what the reported lines leave unexplained.

Financial statements

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Sept 2026
Income
Revenue 18.4 15.4 14.2 13.2 11.8 12.4 12.2 12.5 12.6 12.5 11.7
Gross profit 15.4 12.7 11.8 11.1 9.8 10.3 10.2 10.5 10.7 10.6 10.0
EBITDA 0.2 −1.0 0.9 1.3 1.7 1.9 1.4 1.5 1.0 1.9 1.7
Operating income −0.9 −1.9 0.2 0.7 1.1 1.4 0.8 1.0 0.5 1.5 1.3
Net income −1.7 −2.5 −0.8 −0.7 0.5 0.2 0.0 −0.1 −0.5 0.5 0.0
Diluted EPS −$15.54 −$22.00 −$6.99 −$5.93 $4.39 $1.76 $0.35 −$1.02 −$3.90 $3.77 $0.26
Growth (year on year)
Revenue — −16.7% −7.8% −6.7% −10.8% +4.9% −1.3% +2.3% +1.2% −1.2% −7.8%
EBITDA — — — +38.5% +33.9% +15.3% −30.2% +7.9% −29.7% +86.2% −3.5%
Operating income — — — — +73.2% +24.5% −41.4% +16.6% −43.4% +174.5% −3.9%
Net income — — — — — −55.0% — — — — −89.1%
Diluted EPS — — — — — −59.9% — — — — −89.2%
Margins
Gross margin 83.7% 82.6% 83.4% 83.7% 83.3% 83.5% 83.8% 84.0% 84.6% 85.1% 85.5%
EBITDA margin 1.3% −6.6% 6.4% 9.5% 14.3% 15.7% 11.1% 11.7% 8.1% 15.3% 14.6%
Operating margin −4.7% −12.2% 1.5% 4.9% 9.6% 11.3% 6.7% 7.7% 4.3% 11.9% 10.9%
Net margin −9.3% −16.0% −5.6% −5.1% 4.3% 1.9% 0.4% −1.1% −4.1% 4.1% 0.3%
Free-cash-flow margin 2.1% 1.4% −1.8% −0.4% 14.7% −4.9% −0.9% −2.1% 0.9% 1.7% −1.0%
Cash flow
Cash from operations 1.1 0.8 0.3 0.4 2.2 −0.1 0.3 0.2 0.5 0.5 0.2
Capital spending 0.7 0.6 0.5 0.4 0.4 0.5 0.4 0.5 0.4 0.3 0.3
Free cash flow 0.4 0.2 −0.3 −0.1 1.7 −0.6 −0.1 −0.3 0.1 0.2 −0.1
Stock-based pay 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Free cash flow after stock pay 0.3 0.2 −0.3 −0.1 1.7 −0.6 −0.1 −0.3 0.1 0.2 −0.1
Balance sheet
Cash 0.2 0.6 0.2 0.2 1.7 0.5 0.1 0.0 0.0 0.3 0.2
Total debt 15.4 14.1 13.8 13.6 12.5 12.6 12.0 11.8 11.7 10.6 9.6
Net debt (negative = net cash) 15.2 13.5 13.6 13.3 10.8 12.1 11.9 11.8 11.7 10.4 9.4
Diluted shares 111m 112m 113m 114m 117m 131m 130m 130m 132m 135m 136m

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

1 of 4 checks passed · September 30, 2026
What it owns · $12.1bn
Short-term assets $3.0bnLonger-term assets $9.1bn
What it owes, and who funded it · $13.0bn
Short-term liabilities $2.0bnLonger-term liabilities $11.0bnShareholders' equity $-1.5bn
  • Short-term assets cover short-term liabilities $3.0bn of assets due within a year against $2.0bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities $3.0bn short-term assets against $11.0bn of longer-dated liabilities.
  • More cash than debt $155m of cash against $9.6bn of debt.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt $211m of operating cash flow against $9.6bn of debt.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Community Health Systems Inc's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Diluted share count
+1.5%
year over year
Days sales outstanding
66 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in hospitals
Last 12 months unless stated CYH ARDT EHC THC MD Median
Revenue, last 12 months $11.7bn $6.4bn $6.2bn $22.2bn $2.0bn $6.4bn
Revenue growth, last 12 months −7.8% 3.3% 9.5% 6.2% 1.9% 3.3%
Revenue growth, 3-year average −2.2% — 10.7% 3.2% −0.9% 1.2%
Revenue growth, latest quarter −10.7% −1.4% 9.6% 6.5% 1.7% 1.7%
Operating margin 10.9% — 12.4% 24.4% 10.9% 11.6%
Operating margin, 3-year average 8.7% — 12.8% 23.0% 3.4% 10.7%
Net margin 0.3% 1.2% 10.0% 13.1% 7.7% 7.7%
Cash from operations / revenue 1.8% 8.0% 19.5% 19.1% 11.6% 11.6%
Free-cash-flow margin −1.0% 5.5% 6.7% 15.0% 10.7% 6.7%
Free-cash-flow margin, 3-year average 0.0% 3.3% 6.2% 11.2% 10.2% 6.2%
Stock pay / revenue 0.1% — 0.9% 0.6% 1.1% 0.8%
Change in share count 1.5% 1.3% −1.0% −8.4% −2.8% −1.0%

Median of all 5 companies we cover in hospitals. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

5 hospitals companies
Measure Company Peer median Rank
Revenue growth Growth -7.8% 3.3% 5 of 5
Change in growth rate Growth -2.6pp -0.6pp 4 of 5
Net margin Profitability 0.3% 7.7% 5 of 5
Free-cash-flow margin Cash generation -1.0% 6.7% 5 of 5
Long-term debt as % of assets Balance sheet 79.0% 34.8% 5 of 5
Change in share count Balance sheet 1.5% -1.0% 5 of 5
Days sales outstanding Balance sheet 66 days 43 days 5 of 5

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Managed Care and Other Third Party Payors $6B 47.9% ▼ 1.7%
Medicare Managed Care $2.3B 18.0% ▲ 0.4%
Medicare $2.2B 17.4% ▼ 4.8%
Medicaid $2B 15.9% ▲ 6.5%
Self Pay Revenue $96M 0.8% ▼ 40.7%

From Community Health Systems Inc's 10-K filed February 19, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$389M
Institutions reporting
179
Shares held vs prior quarter
▲ 7.4%
Positions opened / closed
30 / 24

Top buyers and sellers, Q2 2026: 95 institutions bought and 76 sold ; the biggest buyer was SG Americas Securities, LLC (+2.7M shares) and the biggest seller Marshall Wace, LLP (−1.2M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Castleknight Management LP $44.7M 13.4M 11.5% ▲ 5.7%
Apollo Management Holdings, L.P. $39.6M 11.9M 10.2% ▲ 3.2%
Blackrock, Inc. $36.5M 10.9M 9.4% ▲ 11.5%
Eversept Partners, LP $26.3M 7.9M 6.7% ▼ 9.4%
Nomura Holdings Inc $22.4M 6.7M 5.8% ▼ 2.6%
Vanguard Capital Management LLC $17.7M 5.3M 4.5% ▼ 1.6%
Whitebox Advisors LLC $12.5M 3.7M 3.2% ▲ 19.3%
Geode Capital Management, LLC $10.6M 3.2M 2.7% ▲ 8.9%
State Street Corp $10.2M 3.1M 2.6% ▲ 4.8%
Vanguard Portfolio Management LLC $10.1M 3.0M 2.6% ▲ 0.8%
Saba Capital Management, L.P. $9.6M 2.9M 2.5% ▲ 124.8%
SG Americas Securities, LLC $9.1M 2.7M 2.3% ▲ 8159.3%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Community Health Systems Inc's complete shareholder register. Values are as reported by the filers ; 1 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $118,400 1 trade by 1 insider · 0% under pre-set plans
Net ▼ $118,400 net selling
Insider Date Trade Shares Price Value
Jennings William Norris Director August 25, 2026 Sell 40,000 $2.96 $118,400

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around February 17, 2027 estimated from the company's past filing pattern, not announced

  • October 28, 2026
  • July 22, 2026
  • April 21, 2026
  • February 18, 2026
  • October 23, 2025
  • July 23, 2025

Recent SEC filings

Data status

When each part of this page on Community Health Systems Inc was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Community Health Systems Inc in brief

What does Community Health Systems Inc do?
Community Health Systems Inc is a US-listed company in the hospitals industry. Its financial year ends in December.
What is Community Health Systems Inc's stock ticker?
Community Health Systems Inc trades under the ticker CYH on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Community Health Systems Inc's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Community Health Systems Inc reported revenue of $11.7B, 7.8% lower than a year earlier, according to its SEC filings.
What is Community Health Systems Inc's free cash flow?
Community Health Systems Inc's free-cash-flow margin is -1.0% of revenue over the trailing twelve months, ranking 5 of the 5 hospitals companies we cover.
Who are Community Health Systems Inc's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Castleknight Management LP, Apollo Management Holdings, L.P. and Blackrock, Inc. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Community Health Systems Inc's market cap?
On November 2, 2026, Community Health Systems Inc's market capitalisation was about $285M, with a price-to-earnings ratio of 7.9 and net debt of $9.4B. Market figures come from third-party market data and may be delayed.
Who are Community Health Systems Inc's competitors?
In our Hospitals peer group, the companies closest to Community Health Systems Inc are Ardent Health, Inc., Encompass Health Corp, Tenet Healthcare Corp and Pediatrix Medical Group, Inc. The side-by-side comparison below sets their revenue, margins and growth against Community Health Systems Inc's.
Are insiders buying or selling Community Health Systems Inc stock?
Over the last 12 months, Community Health Systems Inc's directors and officers reported 0 open-market purchases and 1 sales on Form 4. The insider trading page charts every trade.
When is Community Health Systems Inc's next earnings date?
Around February 17, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Community Health Systems Inc announces its own schedule.